Superoxide generated by lysophosphatidylcholine induces endothelial nitric oxide synthase downregulation in human endothelial cells

Cellular Physiology and Biochemistry

Volumn 25, Issue 2-3, 2010, Pages 233-240

  Choi, Shinkyu ^a,b   Park, Seonghee ^a   Liang, Guo Hua ^a   Kim, Ji Aee ^a   Suh, Suk Hyo ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Endothelial cell; ENOS; Lysophosphatidylcholine; Superoxide; Vascular dysfunction

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROQUINONE; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TERT BUTYL HYDROPEROXIDE; TETRATHIOMOLYBDATE AMMONIUM; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

EID: 76249115311     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276557     Document Type: Article

References (38)

1. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000;87:840-844.
2. Holvoet P: Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. Ther Apher 1999;3:287-293.
3. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G: Lectin-like, oxidized low-density lipoprotein receptor-1 (lox-1): A critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006;69:36-45. (Pubitemid 41814809)
4. Shah AM, MacCarthy PA: Paracrine and autocrine effects of nitric oxide on myo-cardial function. Pharmacol Ther 2000;86:49-86.
5. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
6. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A: Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circ Res 2006;99:924-932.
7. Matsumoto T, Kobayashi T, Kamata K: Role of lysophosphatidylcholine (lpc) in atherosclerosis. Curr Med Chem 2007;14:3209-3220.
8. Gimbrone MA, Jr., Cybulsky MI, Kume N, Collins T, Resnick N: Vascular endothe-lium. An integrator of pathophysiologi-cal stimuli in atherogenesis. Ann N Y Acad Sci 1995;748:122-131; discussion 131-1122
9. O'Donnell VB, Chumley PH, Hogg N, Bloodsworth A, Darley-Usmar VM, Freeman BA: Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochem 1997;36:15216-15223.
10. Searles CD: Transcriptional and posttranscriptional regulation of en-dothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 2006;291:C803-816.
11. Engelmann J, Volk J, Leyhausen G, Geurtsen W: Ros formation and glutath-ione levels in human oral fibroblasts exposed to tegdma and camphorquinone. J Biomed Mater Res B Appl Biomater 2005;75:272-276.
12. Croset M, Brossard N, Polette A, Lagarde M: Characterization of plasma unsatu-rated lysophosphatidylcholines in human and rat. Biochem J 2000;345 Pt 1:61-67.
13. Okita M, Gaudette DC, Mills GB, Holub BJ: Elevated levels and altered fatty acid composition of plasma lysophosphati-dylcholine(lysopc) in ovarian cancer patients. Int J Cancer 1997;71:31-34.
14. Zmijewski JW, Landar A, Watanabe N, Dickinson DA, Noguchi N, Darley-Usmar VM: Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem Soc Trans 2005;33:1385-1389.
15. Dixit K, Moinuddin, Ali A: Immunologi-cal studies on peroxynitrite modified human DNA. Life sciences 2005;77:2626-2642.
16. Duprat F, Girard C, Jarretou G, Lazdunski M: Pancreatic two p domain k+ channels talk-1 and talk-2 are activated by nitric oxide and reactive oxygen species. J Physiology 2005;562:235-244.
17. Carpenter A, Rassam A, Jennings MH, Robinson-Jackson S, Alexander JS, Erkuran-Yilmaz C: Effects of ammonium tetrathiomolybdate, an oncolytic/ angiolytic drug on the viability and proliferation of endothelial and tumor cells. Inflamm Res 2007;56:515-519.
18. Merla R, Ye Y, Lin Y, Manickavasagam S, Huang MH, Perez-Polo RJ, Uretsky BF, Birnbaum Y: The central role of ad-enosine in statin-induced erk1/2, akt, and enos phosphorylation. Am J Physiol 2007;293:H1918-1928.
19. Vouyouka A G, Jiang Y, Rastogi R, Basson MD: Ambient pressure upregulates nitric oxide synthase in a phosphorylated-ex-tracellular regulated kinase-and protein kinase c-dependent manner. J Vasc Surg 2006;44:1076-1084.
20. Frank GD, Eguchi S, Motley ED: The role of reactive oxygen species in insulin signaling in the vasculature. Antioxid Redox Sig 2005;7:1053-1061.
21. Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, Li YJ: Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the nadph oxi-dase pathway in endothelial cells. Vascul Pharmacol 2006;44:143-148.
22. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R: Serum from patients with severe heart failure downregulates enos and is proapoptotic: Role of tumor necrosis factor-alpha. Circulation 1999;100:1983-1991.
23. Eto M, Barandier C, Rathgeb L, Kozai T, Joch H, Yang Z, Luscher TF: Thrombin suppresses endothelial nitric oxide syn-thase and upregulates endothelin-con-verting enzyme-1 expression by distinct pathways: Role of rho/rock and mitogen-activated protein kinase. Circ Res 2001;89:583-590.
24. Liao JK, Shin WS, Lee W Y, Clark SL: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995;270:319-324.
25. Ladage D, Brixius K, Steingen C, Mehlhorn U, Schwinger RH, Bloch W, Schmidt A: Mesenchymal stem cells induce endothelial activation via paracine mechanisms. Endothelium 2007;14:53-63.
26. Wolfram Kuhlmann CR, Wiebke Ludders D, Schaefer CA, Kerstin Most A, Backenkohler U, Neumann T, Tillmanns H, Erdogan A: Lysophosphatidylcholine- induced modulation of ca(2+)-activated k(+)channels contributes to ros-depend-ent proliferation of cultured human en-dothelial cells. J Mol Cell Cardiol 2004;36:675-682.
27. Michel JB, Feron O, Sacks D, Michel T: Reciprocal regulation of endothelial nitric-oxide synthase by ca2+-calmodulin and caveolin. J Biol Chem 1997;272:15583-15586.
28. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG: Transcrip-tional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000;86:347-354.
29. Gousset-Dupont A, Robert V, Grynberg A, Lacour B, Tardivel S: The effect of n-3 pufa on enos activity and expression in ea hy 926 cells. Prostaglandins Leukot Essent Fatty Acids 2007;76:131-139.
30. Grzenkowicz-Wydra J, Cisowski J, Nakonieczna J, Zarebski A, Udilova N, Nohl H, Jozkowicz A, Podhajska A, Dulak J: Gene transfer of cuzn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 2004;264:169-181.
31. Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP, Donate F: Superoxide dismutase 1 (sod1) is essential for h2o2-mediated oxidation and inactivation of phosphatases in growth factor signaling. PNAS USA 2008;105:7147-7152.
32. Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, Teh BT: Inhibition of mapk kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res 2008;68:81-88.
33. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M: Thymoquinone inhibits tumor ang-iogenesis and tumor growth through suppressing akt and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 2008;7:1789-1796.
34. Liu WH, Cheng YC, Chang LS: Ros-me-diated p38alpha mapk activation and erk inactivation responsible for upregulation of fas and fasl and autocrine fas-mediated cell death in taiwan cobra phospholi-pase a(2)-treated u937 cells. J Cell Physiol 2009;219:642-651.
35. Ray R, Shah AM: Nadph oxidase and en-dothelial cell function. Clin Sci (Lond) 2005;109:217-226.
36. Andalibi A, Liao F, Imes S, Fogelman AM, Lusis AJ: Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor nf-kappa b. Biochem Soc Trans 1993;21:651-655.
37. Martin-Ventura JL, Blanco-Colio LM, Munoz-Garcia B, Gomez-Hernandez A, Arribas A, Ortega L, Tunon J, Egido J: Nf-kappab activation and fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: Potential implication in plaque instability. Stroke 2004;35:458-463.
38. Thors B, Halldorsson H, Clarke GD, Thorgeirsson G: Inhibition of akt phos-phorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase c. Atherosclerosis 2003;168:245-253.